UK Ibrance Patient Program (IPP) Study

Clinical trial NCT03921866 · COMPLETED

Trial details

NCT number: NCT03921866
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

HR+/HER2- Locally Advanced, Metastatic Breast Cancer

Start date: 2019-03-01
Primary completion: 2021-03-04
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.